PRIMARY SIGNET RING – LIKE CELL CARCINOMA OF PROSTATE: A CASE REPORT IN HOSPITAL OF THAI NGUYEN UNIVERSITY OF MEDICINE AND PHARMACY AND LITERATURE REVIEW

Hoàng Thị Luân; Nguyễn Thị Thủy

doi:10.34238/tnu-jst.4296

PRIMARY SIGNET RING – LIKE CELL CARCINOMA OF PROSTATE: A CASE REPORT IN HOSPITAL OF THAI NGUYEN UNIVERSITY OF MEDICINE AND PHARMACY AND LITERATURE REVIEW

About this article

Received: 09/04/21 Revised: 21/05/21 Published: 08/06/21

Authors

1. Hoang Thi Luan , TNU - University of Medicine and Pharmacy
2. Nguyen Thi Thuy, TNU - University of Medicine and Pharmacy

Abstract

Primary signet ring-like cell carcinoma of prostate is a rare tumor with confusing histopathological features. The diagnostic goal is to determine this variant based on histopathological criteria and the results of staining by immunohistochemistry with PSA-specific antibodies of the prostate gland, to know tumor progression as well as behavior in clinical treatment. We used descriptive study to report a rare case: 87-year-old male patient with diagnosis of primary signet ring-like cell carcinoma of prostate in Hospital of Thai Nguyen University of Medicine and Pharmacy and review in the literature this tumor. The results showed that the histopathology after laparoscopic resection on this patient had 30% tumor cell like ring-cell with eccentric nuclei, immuno-histochemical stained with PSA’s positive result. Conclusion: Primary ring-like cell carcinoma of the prostate is a rare variant with distinct microscopic features. According to the literature, patients are often in advanced disease stage, with a short survival time, and therefore need to be treated aggressively and following closely.

Keywords

Signet ring – like cell carcinoma; Signet ring cell; Prostate carcinoma; Prostate; Acinar adenocarcinoma

Full Text:

PDF (Tiếng Việt)

References

[1] P. A. Humphrey, H. Moch, and A. L. Cubilla, “The 2016 WHO Classification of Tumor of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours,” Eur Urol, vol. 70, no. 1, pp. 106-119, 2016.

[2] J. N. Warner, L. Y. Nakamura, A. Paceli, M. R. Humphreys, and E. P. Castle, “Primary signet ring cell carcinoma of the prostate,” Mayo Clin Proc, vol. 85, no. 12, pp. 1130-1136, 2010.

[3] K. T. Nguyen, “Studying about the expression of PD-1 and comparison with the histopathology of prostate carcinoma,” Master in medicine, Ha Noi Medical University, Ha Noi, 2018.

[4]. T. D. Ho, “Histopathological study and the rate of immunohistochemistry on prostate carcinoma core biopsies,” Graduation thesis as a resident doctor, Ha Noi Medical University, Ha Noi, 2012.

[5]. K. V. Le, “Histopathological characteristics and the expression of some immunohistochemistry markers in the diagnosis of prostate adenocarcinoma core biopsies,” Graduation thesis as a resident doctor, Ha Noi Medical University, Ha Noi, 2017.

[6] P. A. Humphrey, “Histopathology of Prostate Cancer,” Cold Spring Harb Perspect Med, vol. 7, no.10, pp. a030411, 2017.

[7] K. Fujita, H. Sugao H, T. Gotoh, S. Yokomizo, and Y. Itoh, “Primary signet ring cell carcinoma of the prostate: report and review of 42 cases,” Int J Urol, vol. 11, no. 3, pp. 178-181, 2004.

[8] J. Y. Ro, A. el-Naggar, A. G. Ayala, D. R. Mody, and N. G. Ordonez, “Singnet ring cell carcinoma of the prostate. Electron-microscopic and immunohistochemical studies of eight cases,” Am J Surg Pathol, vol. 12, no. 6, pp. 4533-4560, 1988.

[9] A. Gupta and H. V. Gulwani, “A rare case of primary signet ring-like cell carcinoma of prostate in an elderly male,” Indian J Pathol Microbiol, vol. 63, no. 2, pp. 338-339, 2020.

[10] D. L. C. Pinta and M. Martin, “A Case with Primary Signet Rig Cell Adenocarcinoma of the Prostate and Review of the Literature,” J Cancer Prev Curr Res, vol. 7, no. 6, 2017, Art. no. 00258.

[11] J. N. Kabalin, J. E. McNeal, and I. M. Johnstone, “Serum prostate-specific antigen and the biologic progression of prostate cancer,” Urology, vol. 46, no. 1, pp. 65-70, 1995.

[12] J. A. Cadeddu, J. D. Pearson, and A. W. Partin, “Relationship between changes in prostate-specific antigen and prognosis of prostate cancer,” Urology, vol. 42, no. 4, pp. 383-389, 1993.

[13] T. L. Randolph, M. B. Amin, J. Y. Ro, and A. G. Ayala, “Histologic variant of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance,” Mod Pathol, vol. 10, no. 6, pp. 612-629, 1997.

DOI: https://doi.org/10.34238/tnu-jst.4296

Refbacks

There are currently no refbacks.



Remember me